Delhi High Court grants interim injunction to SmithKline Beecham Limited for its ‘GSK’ mark
“Considering that the plaintiff operates in the pharmaceutical and medicinal sector and is also registered for the ‘GSK’ mark, the use of an identical mark, especially in an identical colour combination, is clearly dishonest and mala fide.”